Navigation Links
New Hip Implant Provides Personalized Fit

WARSAW, Ind., March 11 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a leader in musculoskeletal care, today showcased its recently introduced Continuum Acetabular Cup System at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting.  The Continuum Cup combines the best of Zimmer's proven hip technologies – Trabecular Metal™ Technology, Metasul® Metal-on-Metal technology, BIOLOX® delta and Longevity® Highly Crosslinked Polyethylene – with new innovations in what is now the company's most versatile acetabular cup system.  

Candidates for hip replacement surgery represent a wide array of ages and lifestyle demands. Different patient circumstances require surgeons to consider a variety of implant bearing surfaces to accommodate their patients' needs.  The Continuum Cup gives surgeons the option of choosing between metal or Highly Crosslinked Polyethylene bearing surfaces, and metal or ceramic heads to match a range of patient lifestyles.  

"By creating a system with multiple cup liner options in a range of sizes and configurations, surgeons are able to select the cup and bearing surface which best meet each patient's specific needs, creating a more personalized fit," said Jeff McCaulley, President, Zimmer Reconstructive.  "In combination with our comprehensive stem portfolio, including our Fitmore® Hip Stem and our M/L Taper with Kinectiv® technology, Zimmer offers surgeons tremendous flexibility and confidence to personalize the implant solution."

Continuum shells are made with Zimmer's proprietary Trabecular Metal Technology, a highly porous tantalum material that supports initial implant stability and fixation.  Trabecular Metal Technology is conducive to more normal bone formation and bone in-growth, decreased stress-shielding, and the potential for improved long-term implant fixation.  The Metasul liner incorporates Zimmer's Metasul Metal-on-Metal technology, which has more than 20 years of clinical history.  Longevity, the principal technology behind the polyethylene liner, is highly resistant to wear and aging and has more than 10 years of clinical experience.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products.  Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries.  Zimmer's 2009 sales were approximately $4.1 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.

For more information about Zimmer, visit

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management.  Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially.  For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission.  We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports.  Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.

SOURCE Zimmer Holdings, Inc.

Back to top



SOURCE Zimmer Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GelFix(TM) Posterior Spinal Distraction Implant Receives CE Mark
2. Ferring Pharmaceuticals and Gene Security Network Partner to Test Advanced Preimplantation Genetic Diagnosis (PGD) Technology
3. American Heart Association Rapid Access Journal Report: Implanted Monitor Accurately Detects Heart Rhythm Disturbances
4. AHRQ and American College of Cardiology Collaborate On Study of Implantable Cardioverter Defibrillators
5. Smith & Nephew Orthopaedics Begins Distribution to Haiti of Trauma Implants and Instruments
6. WorldHeart Announces First U.S. Implant of Levacor(TM) VAD Implant at INTEGRIS in Oklahoma City
7. FDA Advisory Panel Votes 15 to 0 in Favor of Approving Envoy Medicals Esteem(R) Fully Implantable Hearing Restoration System
8. Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009
9. Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly
10. Reportlinker Adds European Markets for Spinal Implants, MIS, and VCF 2009 (15 Countries)
11. LifeNet Health Announces First Bio-Implant with New Preservation Technology
Post Your Comments:
(Date:11/30/2015)... BOCA RATON, Fla. , Nov. 30, ... of Public Research (the Institute) announced today that ... , a medical device start-up company with technology developed ... creation based on publicly-funded research, and bridges early funding ... -based universities and research institutions. ...
(Date:11/30/2015)... Nov. 30, 2015 Baxalta Incorporated ... leader dedicated to delivering transformative therapies to ... conditions, today announced the launch and first ... an extended circulating half-life recombinant factor VIII ... full-length ADVATE [Antihemophilic Factor (Recombinant)]. The treatment ...
(Date:11/30/2015)... Months Ended 30 September 2015 2014RestatedChange%Turnover 545,575 , 518,852 , ... 384,242 , 9.8 Hospital Management Service Income ... (18.3) Medical Insurance Administration Service Income , 2,780 ... and Accessories Sales , 89,645 , 94,580 ... 2,822 , 2,917 , (3.3) Gross ...
Breaking Medicine Technology:
(Date:11/30/2015)... , ... November 30, 2015 , ... Cycling, running, and ... take on extra meaning the morning of February 28, 2016. , That’s when ... Park and thousands will exercise to help children and families at Joe DiMaggio ...
(Date:11/30/2015)... ... November 30, 2015 , ... A ... of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of ... Their study showed that small molecule analogs that target the functions of SecA, ...
(Date:11/30/2015)... ... November 30, 2015 , ... Using a combination of two blood ... children and adults, according to a new study by researchers at the School of ... Children and Adults: Using Combinations of Blood Glucose Tests ,” published in Frontiers in ...
(Date:11/30/2015)... ... November 30, 2015 , ... International telepathology consultations can ... and KingMed Diagnostics researchers. Their review of more than 1,500 pathology ... pathologists resulted in significantly altered treatment plans for more than half of the ...
(Date:11/30/2015)... PHILADELPHIA (PRWEB) , ... November 30, 2015 , ... ... Philadelphia-based non-profit promoting breast and prostate cancer education and prevention—is joining forces with ... evening of philanthropy and Hollywood elegance on December 7, 2015 at the Union ...
Breaking Medicine News(10 mins):